Table 1.
Correlation of CXCR2 expression with clinicopathological characteristics in patients with glioma
| Clinicopathological parameters | No | CXCR2 expression
|
P-valuea | |
|---|---|---|---|---|
| Low (including negative) | High | |||
| Total cases | 75 | |||
| Normal | 15 | 15 (13) | 0 | 0 |
| Glioma | 60 | 19 (10) | 41 | |
| WHO glioma grade | 0.00015 | |||
| I–II | 29 | 16 (8) | 13 | |
| III–IV | 31 | 3 (2) | 28 | |
| Sex | 0.1521 | |||
| Male | 36 | 13 (7) | 23 | |
| Female | 24 | 6 (3) | 18 | |
| Age (years) | 0.21216 | |||
| ≤45 | 27 | 9 (5) | 18 | |
| >45 | 33 | 10 (5) | 23 | |
| Recurrence | 0.02009 | |||
| Recurrent | 25 | 4 (2) | 21 | |
| Primary | 35 | 15 (8) | 20 | |
Notes:
a
Statistical analyses were conducted using Fisher’s exact probability. P<0.05 was considered as statistically significant.
Abbreviations: CXCR2, C-X-C chemokine receptor 2; WHO, World Health Organization.